FDA Complete Response letter delays approval of J&J’s carisbamate

Article | 28 August 2009

The US Food and Drug Administration (FDA) issued a complete response letter regarding the New Drug Application for carisbamate, an ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in